What is the clinical significance and management approach for a 23-year-old female patient with low normal Total Testosterone, low SHBG, normal Free and Bioavailable Testosterone, and elevated Insulin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Laboratory Results for a 23-Year-Old Female Patient

The laboratory results indicate Polycystic Ovary Syndrome (PCOS) with insulin resistance as the most likely diagnosis, characterized by low SHBG, elevated insulin, and normal free testosterone despite low-normal total testosterone.

Laboratory Findings Analysis

Key Abnormal Results:

  • Sex Hormone Binding Globulin (SHBG): 19.2 nmol/L (low, reference range: 24.6-122.0)
  • Insulin Total Random: 33.2 uIU/mL (elevated, reference range: 2.6-24.9)
  • Total Testosterone: 20.30 ng/dL (low-normal, reference range: 8.00-48.00)

Normal Results:

  • Free Testosterone: 5 pg/mL (normal, reference range: 1-7)
  • Bioavailable Testosterone: 11 ng/dL (normal, reference range: 2-21)
  • Free Testosterone Percent: 2.31% (normal, reference range: 1.60-2.90)
  • Prolactin: 20.00 ng/mL (normal, reference range: 4.79-23.30)
  • DHEA: 346 ng/dL (normal)
  • 17-Hydroxyprogesterone: 26.26 ng/dL (normal, reference range: ≤206.00)

Clinical Significance

  1. Low SHBG with Normal Free Testosterone:

    • SHBG is primarily decreased by insulin resistance 1, 2
    • Low SHBG increases the bioavailable fraction of testosterone even when total testosterone is low-normal 2, 3
    • This pattern is characteristic of PCOS 1
  2. Elevated Insulin:

    • Indicates insulin resistance, a key pathophysiological feature of PCOS 1
    • Insulin resistance directly suppresses hepatic SHBG production 4
    • Associated with increased cardiovascular risk 5, 6

Management Approach

Diagnostic Confirmation

  • Assess for other PCOS criteria:
    • Menstrual irregularity (oligomenorrhea: >35 days between cycles, or amenorrhea: no bleeding >6 months) 1
    • Clinical signs of hyperandrogenism (hirsutism, acne, male pattern hair loss)
    • Polycystic ovaries on ultrasound (>10 peripheral cysts, 2-8mm diameter) 1

First-Line Treatment: Lifestyle Modifications

  • Weight management is critical for improving insulin sensitivity and SHBG levels 7
  • Recommend:
    • Regular physical activity: 150 minutes of moderate-intensity exercise weekly 7
    • Balanced diet with moderate carbohydrate consumption 7
    • Target 5-10% weight loss if overweight/obese

Medication Considerations

  • Metformin may be indicated to improve insulin sensitivity
  • Combined oral contraceptives can be considered to:
    • Regulate menstrual cycles
    • Increase SHBG levels
    • Reduce free androgen levels

Monitoring

  • Follow-up in 3-6 months to assess:
    • Insulin levels
    • SHBG levels
    • Free and total testosterone
    • Clinical symptoms (menstrual regularity, hirsutism)

Clinical Pearls and Pitfalls

  • Important: Free testosterone calculation is more reliable than Free Androgen Index (FAI) for monitoring bioavailable testosterone 3
  • Caution: Normal free testosterone with low SHBG can mask underlying hormonal imbalances if only total testosterone is measured 2
  • Remember: Insulin resistance and low SHBG are independently associated with metabolic syndrome and cardiovascular risk 5, 6
  • Note: The pathogenesis of PCOS involves acceleration of pulsatile GnRH secretion, insulin resistance, and downstream metabolic dysregulation 1

Long-term Considerations

  • Monitor for development of metabolic syndrome components:
    • Dyslipidemia
    • Hypertension
    • Glucose intolerance/diabetes
  • Assess cardiovascular risk factors regularly
  • Consider screening for mood disorders, which are common in PCOS

This pattern of laboratory findings strongly suggests PCOS with insulin resistance as the underlying pathophysiology, requiring lifestyle interventions as the cornerstone of management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.